GoodRx Holdings Enhances Visibility at Key Investor Conferences for Healthcare Affordability

GoodRx Strengthens Industry Presence with Upcoming Conferences

GoodRx Holdings, Inc., a frontrunner in the U.S. prescription savings sector, is set to enhance its visibility and engagement within the healthcare community by participating in two key investor conferences. The company’s executives will take part in a fireside chat at the UBS 2024 Global Healthcare Conference on November 12, 2024, and will also feature at the Citi 2024 Global Healthcare Conference on December 5, 2024. These gatherings present an opportunity for GoodRx to showcase its innovative solutions and communicate its strategic vision to a broader audience of investors and healthcare professionals.

The participation in these conferences highlights GoodRx's commitment to transparency and investor relations. As a platform that has assisted over 25 million consumers and 750,000 healthcare professionals annually, GoodRx emphasizes the importance of providing accessible information about medication savings. Since its inception in 2011, the company has played a pivotal role in helping consumers save more than $75 billion on prescriptions, which underscores its impact on healthcare affordability in the U.S. By engaging with key stakeholders through these events, GoodRx aims to reinforce its leadership position in the prescription savings market.

Moreover, GoodRx’s decision to offer live webcasts of its conference appearances, along with archived recordings, demonstrates its dedication to maintaining an open dialogue with investors. This approach not only meets regulatory obligations but also serves as a valuable resource for anyone interested in the company’s operational updates and developments. The company encourages investors to utilize its website for ongoing insights, ensuring that they remain informed about its initiatives and performance in the evolving healthcare landscape.

In addition to its conference engagements, GoodRx continues to enhance its offerings in medication savings and healthcare research. The platform is renowned for providing critical information that helps consumers navigate the complexities of prescription costs, thereby improving access to both generic and brand-name medications. This commitment to affordability and transparency positions GoodRx as a vital player in the healthcare industry, particularly as healthcare costs remain a pressing concern for many Americans.

As GoodRx prepares for its upcoming conferences, the company remains focused on its mission to facilitate better healthcare access and savings for consumers nationwide. By actively participating in industry discussions, GoodRx not only strengthens its brand presence but also contributes to a broader conversation about the future of healthcare affordability in the United States.